Lexaria Bioscience Corp. (LEXX)

Lexaria Bioscience Revenue

Lexaria Bioscience had revenue of $194.00K in the twelve months ending May 31, 2026, down -68.50% year-over-year. In the fiscal year ending August 31, 2025, Lexaria Bioscience had annual revenue of $705.92K with 52.05% growth.

• Revenue (ttm): $194.00K
• Revenue Growth: -68.50%
• P/S Ratio: 23.59
• Revenue / Employee: $27,714
• Employees: 7
• Market Cap: 4.79M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Aug 31, 2025	705.92K	241.65K	52.05%
Aug 31, 2024	464.28K	238.07K	105.24%
Aug 31, 2023	226.21K	-29.19K	-11.43%
Aug 31, 2022	255.40K	-467.34K	-64.66%
Aug 31, 2021	722.74K	407.95K	129.59%
Aug 31, 2020	314.79K	92.18K	41.41%
Aug 31, 2019	222.61K	-210.68K	-48.62%
Aug 31, 2018	433.29K	369.65K	580.85%
Aug 31, 2017	63.64K	22.92K	56.29%
Aug 31, 2016	40.72K	26.02K	176.96%
Aug 31, 2015	14.70K	-	-
Aug 31, 2014	-	-	-
Oct 31, 2013	1.10M	-260.31K	-19.17%
Oct 31, 2012	1.36M	224.00K	19.76%
Oct 31, 2011	1.13M	771.30K	212.79%
Oct 31, 2010	362.47K	-59.48K	-14.10%
Oct 31, 2009	421.96K	-478.83K	-53.16%
Oct 31, 2008	900.79K	647.64K	255.83%
Oct 31, 2007	253.15K	-	-

Data Source: Fiscal.ai Last updated: Jul 13, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 2, 2026

Data Sources Report a data error